COVAX-19 Trademark
Serial Number: 90035922
COVAX-19 is a trademark filed by
GENECURE, LLC
on July 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Trademark Details
Filing Date
July 4, 2020
Registration Date
Not Registered
First Use Anywhere
February 12, 2020
First Use in Commerce
February 12, 2020
Goods & Services
Therapeutic vaccines; Vaccines
Filing History
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 19, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 19, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 19, 2022 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 6, 2022 GNFN
FINAL REFUSAL E-MAILED
Jun 6, 2022 GNFR
FINAL REFUSAL WRITTEN
Jun 6, 2022 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 16, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 28, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 28, 2021 GNSL
SUSPENSION LETTER WRITTEN
Sep 28, 2021 CNSL
ASSIGNED TO EXAMINER
Aug 30, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2021 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 19, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 19, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2020 NWOS
NEW APPLICATION ENTERED
Jul 8, 2020 NWAP